WHO Influenza A(H1N1) – update 8.1

1 May 2009 — The situation continues to evolve. As of 23:30 GMT, 1 May 2009, 13 countries have officially reported 367 cases of influenza A(H1N1) infection.

The United States Government has reported 141 laboratory confirmed human cases, including one death. Mexico has reported 156 confirmed human cases of infection, including nine deaths.

The following countries have reported laboratory confirmed cases with no deaths – Austria (1), Canada (34), China, Hong Kong, Special Administrative Region (1), Denmark (1), Germany (4), Israel (2), Netherlands (1), New Zealand (4), Spain (13), Switzerland (1) and the United Kingdom (8).

Further information on the situation will be available on the WHO website on a regular basis.

WHO advises no restriction of regular travel or closure of borders. It is considered prudent for people who are ill to delay international travel and for people developing symptoms following international travel to seek medical attention, in line with guidance from national authorities.

There is also no risk of infection from this virus from consumption of well-cooked pork and pork products. Individuals are advised to wash hands thoroughly with soap and water on a regular basis and should seek medical attention if they develop any symptoms of influenza-like illness.

Related WHO links

Influenza A(H1N1) web site
Daily updates will be posted on this site.

Like

Unlike

Author of Emerging Viruses: AIDS And Ebola: Nature, Accident or Intentional?, Horowitz says the swine-bird-human flu strain,  reported to be found first in Mexico in late-March 2009, could have only come from Dr James S. Robertson and his colleagues in association with the US Centre for Disease Control and vaccine manufacturer Novavax, Inc,  which was ready to profit from the release he says.   Nobody else takes H5N1 Asian-flu infected chickens, takes them to Europe, extracts their DNA, combines their proteins with H1N1 viruses from the 1918 Spanish flu isolate, additionally mixes in some swine-flu genes from pigs, then reverse engineers them to infect humans, he said.

A report in Medical News Today revealed that Novavax was working on a vaccine for an avian flu pandemic in 2005 and an article at News-Medical.net mentioned they began human clinical testing of a pandemic flu vaccine in August 2007.   Also, in a news release dated the 14th of April 2009, shortly after the first reported case of “swine flu”, their vaccine was being touted as being able to protect against the “highly pathogenic H5N1 avian influenza strain.”  Stated the Vice President of Vaccine Development for Novavax in this report, the vaccine  “has significant implications for both pre-pandemic and pandemic preparedness.”

Like

Unlike